Metraipolis › archive › dc_2b021252f6de
2240 nm NIR-IV Photodynamic Therapy Can Reverse Ineffective Anti-OX40 Cancer Immunotherapy to Become Effective — Europe PMC PMID:41075187
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41075187
- DOI
- 10.1021/acsnano.5c04323
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T09:53:38.020Z
- SHA-256 of the archived text
9c7e238b039d4cc134c9fef97e4bb905520a777d76beccb3fe3b3d2a773c1393- Stable URL of this page
https://metraipolis.com/documento/dc_2b021252f6de
How to cite
2240 nm NIR-IV Photodynamic Therapy Can Reverse Ineffective Anti-OX40 Cancer Immunotherapy to Become Effective — Europe PMC PMID:41075187 — Europe PMC (en), https://europepmc.org/article/MED/41075187 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b021252f6de (Metraipolis archive dc_2b021252f6de, sha256 9c7e238b039d4cc134c9fef97e4bb905520a777d76beccb3fe3b3d2a773c1393)
BibTeX
@misc{dc2b021252f6de,
title = {2240 nm NIR-IV Photodynamic Therapy Can Reverse Ineffective Anti-OX40 Cancer Immunotherapy to Become Effective — Europe PMC PMID:41075187},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41075187},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b021252f6de; sha256 9c7e238b039d4cc134c9fef97e4bb905520a777d76beccb3fe3b3d2a773c1393},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41075187. Agents can read the archived copy with the MCP tool read_document.